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Background. Alcohol has a negative effect on antiretroviral therapy (ART) adherence and HIV treatment outcomes. 
Method. As part of formative work for a project to test the efficacy of an alcohol-focused intervention to reduce alcohol consumption and 
improve HIV treatment outcomes, we investigated the extent of problem drinking among patients at ART clinics in Tshwane, South Africa 
(SA), using the Alcohol Use Disorders Identification Test (AUDIT). 
Results. The finding that a third of drinkers reported hazardous drinking, roughly 10% reported harmful drinking, and a further 10% were 
possibly alcohol dependent replicates the findings of similar research in the Western Cape and Gauteng provinces of SA. It also points to 
the need for more routine screening of ART patients for problematic alcohol use. 
Conclusion. The 10-item AUDIT may be too time consuming for health workers in busy ART clinics to administer and score, necessitating 
even briefer screening instruments for assessing hazardous and harmful drinking.
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The number of people on antiretroviral therapy (ART) in South 
Africa (SA) is the highest globally, accounting for over 20% of all 
persons on ART worldwide.[1] This places an enormous burden on 
the health budget and on the human and other resources necessary 
to deliver ART to a greater proportion of HIV patients. However, 
increasing access to ART has made HIV a manageable, chronic 
condition. It is well established that hazardous or harmful alcohol 
use is causally linked to HIV disease progression. This occurs 
as a result of the effect of alcohol on ART adherence and on the 
immune system, and its interaction with ART and medications 
used to treat opportunistic infections.[2] Yet little is known about 
the drinking behaviour of patients on ART in SA or how best to 
intervene.
In 2014, the South African Medical Research Council funded a 
randomised controlled trial (RCT) to determine the efficacy of an 
alcohol-focused intervention for improving adherence to ART and 
HIV treatment outcomes.[3] As part of the formative work undertaken 
for this RCT, we investigated the extent of problem drinking among 
patients on ART seen at ART clinics in district hospitals in the 
Tshwane Metropolitan Municipality, Gauteng Province, SA.
Methods
Participants comprised patients who were screened to take part in the 
pilot study of the RCT[3] as they waited for their clinic appointment. 
Patients were eligible to participate if they were at least 18 years old, 
lived in Tshwane or the general area served by the selected clinics, 
were HIV-positive, had been receiving ART for at least 3 months, 
were not currently on treatment for tuberculosis (TB), and were 
not currently enrolled in another study. The Alcohol Use Disorders 
Identification Test (AUDIT) was then completed with consenting 
patients.[4]
The screener collected information on demographic characteristics, 
duration of ART, receipt of TB treatment, and alcohol use during 
the past 12 months. The 10-item AUDIT[4] was administered to 
participants who reported any alcohol consumption in the past year. 
Responses were summed to yield a total score, with a possible range of 
0 - 40. Higher total scores indicate a greater risk for problem drinking. 
The AUDIT cut-off scores of 8 - 15 for hazardous drinking, 16 - 19 
for harmful drinking and ≥20 for possible alcohol dependence were 
used.[4]
Results
The sample comprised 196 participants who reported alcohol use 
in the past 12 months – one-third of those who reached this point 
in the screening process. Of these, 190 completed all items on the 
AUDIT. Roughly half were female (49.5%). Among those who 
reported alcohol use in the past 12 months, a high proportion 
(46%) were in the low-risk category. A third (33%) of the 
participants were in the hazardous risk category, 11% were in the 
harmful risk category and 10% were in the possible dependence 
category. Overall, 69% of male drinkers and 39% of female drinkers 
scored in the highest three risk categories (i.e. total AUDIT score 
≥8). The mean total AUDIT score was significantly higher for 
men (11.4) than for women (7.9) (t=–3.724; p<0.0001). One in 
five female drinkers (21%) reported heavy episodic drinking at 
least once a month, compared with a third (32%) of male drinkers 
(heavy episodic drinking being defined as four or more drinks for 
women and six or more drinks for men).
IN PRACTICE
568        June 2016, Vol. 106, No. 6
Discussion
Although the sample size was relatively small and excluded individuals 
who refused screening or reported no drinking in the past year, the 
findings broadly align with those of Kader et al.,[5] who found that 
91% of male and 89% of female drinkers (most of whom were 
receiving ART) attending eight HIV clinics in Cape Town reported 
hazardous or harmful alcohol consumption when screened with the 
AUDIT. A similar study conducted in Tshwane in two HIV clinics 
among patients on ART found slightly lower corresponding figures 
of 75% for male and 55% for female drinkers, but like the findings of 
Kader et al.,[5] these are somewhat higher than ours reported above.
The high proportions of men and women who drink heavily is of 
grave concern given the associated risk for reduced ART adherence,[6] 
forward transmission of HIV, and other health problems.[7] Given 
the high levels of problematic drinking that were evident among 
patients on ART in Tshwane, we agree with recommendations 
made previously[2,5] that there should be more screening of patients 
attending HIV clinics for problematic alcohol use as a prelude to 
implementing brief interventions to reduce the negative impact of 
drinking on HIV treatment outcome, or where necessary referring 
HIV patients to more intensive treatment. However, the 2 - 4 minutes 
typically taken to administer and score the AUDIT[4] is likely to serve 
as a barrier to its routine use in primary care settings, and as a result 
further research is also needed to assess the possibility of using briefer 
screening instruments in primary care settings.
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